Parathyroid cancer is a very rare type of cancer that starts in the parathyroid gland. It can cause hyperparathyroidism, which can result in high calcium levels in the blood. The most common treatment ...

April 28 (UPI) --Researchers at the University of Texas MD Anderson Cancer Center have created a new prognostic tool to predict the risk of recurrence of parathyroid cancer in patients. More than half ...

September 19, 2007--Cinacalcet ( Sensipar, Amgen) may emerge as an important new therapeutic option for patients with inoperable parathyroid carcinoma, researchers report. According to the results of ...

Even with decades of experience in the healthcare field, Kathy Ross was taken aback when she learned she had a parathyroid tumor. “It was very scary,” said Ross, who is the chief information officer ...

A newly-created prognostic tool reliably predicts the recurrence of parathyroid cancer, enabling physicians to identify patients at the highest risk. Consequently, the tool also helps to determine the ...

Multiple Endocrine Neoplasia Type 1 is a rare genetic disorder associated with a high risk of developing tumors in your parathyroid gland and pituitary gland, and your pancreas. Multiple endocrine ...

The survival of patients with parathyroid cancer is often fairly long, especially if the initial operation is carried out at a specialized endocrine surgery center, shows a new retrospective study.

Phase I dose escalation study of pan-histone deacetylase (HDAC) inhibitor abexinostat in combination with cisplatin in patients with advanced non-keratinizing nasopharyngeal carcinoma. E1308: ...

Primary hyperparathyroidism occurs when the parathyroid glands produce too much parathyroid hormone (PTH). This can lead to health complications. Primary hyperparathyroidism is a relatively common ...

At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer, day in and day out. A handful of people form the core of your care team. You have an oncologist who ...